In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Across the pharmaceutical value chain – from research and development to manufacturing and distribution – users must be equipped with the knowledge and skills required to navigate complex ...

Indirect, because, these platforms are only solving for one touch point in the pharmaceutical value chain. “Our core focus is pharma. And no one, so far, is deep diving into the supply chain ...

and commercial functions to ensure seamless execution across the value chain. In addition, pharmaceutical companies should focus on elevating business acumen, diagnostic capabilities, and ...

"The measures noted above not only improve manufacturing operations, but also play a role in making the entire pharmaceutical value chain more sustainable, with CPOs leading the way," von Kienlin ...

and social outcomes across the global pharmaceutical and healthcare value chain. "We are pleased to join the PSCI as a Supplier Partner and reaffirm our commitment to fostering responsible ...

Respondents also considered target identification to be the component of the pharmaceutical value chain most set to benefit from the incorporation of AI. This was followed by lead generation and ...

Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...